Blogopmaak
DCRT at workshop of the DARTER COST Action
No less than three DCRT coordinators actively contributed to the workshop of the Delivery of Antisense RNA Therapy (DARTER) COST Action that took place from July 19-21. DARTER is a network that aims to foster and facilitate antisense oligonucleotide research in Europe by achieving consensus on which model systems to use to improve delivery and study safety and toxicity of oligonucleotide therapies. COST Actions are funded by the cooperation of science and technology (COST. These networks are open to new participants also after the network has initiated. For more information on DARTER look on the antisenserna website.
During the workshop Willeke van Roon-Mom presented on delivery to brain and cell and animal model systems to test this. Rob Collin presented on delivery to the eye and the development of antisense oligonucleotide therapies for genetic retinal diseases. Finally, Annemieke Aartsma-Rus presented in the “negative results” session. DARTER and DCRT strongly believe that it is important to publish also about hypotheses and ideas that turned out not to work. Sharing these findings will avoid unnecessary duplication of work. Furthermore, hypotheses that are disproven also advance science.
published on Jul 29, 2021
Annemieke Aartsma-Rus presented at the Swiss RNA Therapeutics Summit at the University of Bern
DCRT's Ype Elgersma will talk on television about his work on epilepsy
Happy Christmas holidays from all of us at DCRT!
Guest researchers at the DCRT
Join us on 12 and 13 June 2025 in Groningen, The Netherlands, for the 4th Dutch Antisense Therapeutics Symposium
DCRT interview in the newsletter of Centre for Future Affordable Sustainable Therapy Development (FAST)
DCRT travel grant recipients, Edwin van Oosten and Raúl Andrés about the OTS meeting
First DCRT newsletter
Marlen Lauffer, Emilio Harris-Mostert and Edwin van Oosten received an OTS poster award
Cake and candles for 12.5 years at LUMC